In vitro synergistic effect of retapamulin with erythromycin and quinupristin against Enterococcus faecalis.

Author: MinYu-Hong, ParkByoungduck

Paper Details 
Original Abstract of the Article :
To find a therapeutic alternative for the treatment of skin and soft tissue infections, we evaluated the effects of combinations of retapamulin with macrolide, lincosamide, and streptogramin (MLS) antibiotics against Staphylococcus aureus, Streptococcus pyogenes, Enterococcus faecium, and Enterococc...See full text at original site
Dr.Camel IconDr.Camel's Paper Summary Blogラクダ博士について

ラクダ博士は、Health Journal が論文の内容を分かりやすく解説するために作成した架空のキャラクターです。
難解な医学論文を、専門知識のない方にも理解しやすいように、噛み砕いて説明することを目指しています。

* ラクダ博士による解説は、あくまで論文の要点をまとめたものであり、原論文の完全な代替となるものではありません。詳細な内容については、必ず原論文をご参照ください。
* ラクダ博士は架空のキャラクターであり、実際の医学研究者や医療従事者とは一切関係がありません。
* 解説の内容は Health Journal が独自に解釈・作成したものであり、原論文の著者または出版社の見解を反映するものではありません。


引用元:
https://doi.org/10.1038/s41429-020-0312-7

データ提供:米国国立医学図書館(NLM)

Synergistic Effect of Retapamulin with Erythromycin and Quinupristin against *Enterococcus faecalis*

The battle against antibiotic resistance is a constant struggle, requiring innovative approaches to combat the emergence of drug-resistant bacteria. This study investigates the synergistic effect of retapamulin, a topical antibiotic, with erythromycin and quinupristin against *Enterococcus faecalis*, a common cause of skin and soft tissue infections. It's like a desert fortress, employing a multi-pronged attack to overcome a formidable foe.

A Powerful Combination Against *E. faecalis*

The study reveals that combinations of retapamulin with erythromycin and quinupristin exhibit synergistic activity against *E. faecalis*, even against strains with high-level erythromycin resistance. This is like a desert caravan, employing a team of camels to navigate the treacherous terrain of antibiotic resistance. The study suggests that these combinations could be a promising new strategy for treating *E. faecalis* infections, particularly those resistant to conventional therapies.

New Hope for Treating Antibiotic-Resistant Infections

This research offers a glimmer of hope in the fight against antibiotic resistance. The synergistic effect of retapamulin with erythromycin and quinupristin provides a potential new weapon in the arsenal of antimicrobial agents. It's like discovering a hidden oasis in the desert of antibiotic resistance, offering a new source of protection against these formidable foes.

Dr.Camel's Conclusion

This study provides valuable insights into the potential of synergistic drug combinations to overcome antibiotic resistance. It offers a potential new treatment strategy for *E. faecalis* infections, particularly those resistant to conventional therapies. This research highlights the importance of continued exploration of drug interactions and the potential for synergistic combinations to address the growing threat of antibiotic resistance.

Date :
  1. Date Completed 2020-12-24
  2. Date Revised 2021-03-24
Further Info :

Pubmed ID

32346089

DOI: Digital Object Identifier

10.1038/s41429-020-0312-7

Related Literature

SNS
PICO Info
in preparation
Languages

English

Positive IndicatorAn AI analysis index that serves as a benchmark for how positive the results of the study are. Note that it is a benchmark and requires careful interpretation and consideration of different perspectives.

This site uses cookies. Visit our privacy policy page or click the link in any footer for more information and to change your preferences.